HealthCor Management, L.P. - Q1 2015 holdings

$2.1 Billion is the total value of HealthCor Management, L.P.'s 65 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 121.2% .

 Value Shares↓ Weighting
HZNP SellHORIZON PHARMA PLC$103,880,000
+43.9%
4,000,000
-28.6%
4.96%
+23.2%
MNKKQ SellMALLINCKRODT PUB LTD CO$101,320,000
-22.8%
800,000
-39.6%
4.83%
-33.9%
GILD NewGILEAD SCIENCES INCcall$98,130,0001,000,000
+100.0%
4.68%
LH BuyLABORATORY CORP AMER HLDGS$85,111,000
+43.4%
675,000
+22.7%
4.06%
+22.8%
BIIB NewBIOGEN INC$80,521,000190,700
+100.0%
3.84%
A BuyAGILENT TECHNOLOGIES INCcall$75,829,000
+2.9%
1,825,000
+1.4%
3.62%
-11.9%
AET NewAETNA INC NEW$74,571,000700,000
+100.0%
3.56%
BKD BuyBROOKDALE SR LIVING INC$73,632,000
+262.8%
1,950,000
+252.3%
3.51%
+210.6%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDadr$71,645,000
+338.7%
1,150,000
+304.9%
3.42%
+275.6%
PFE BuyPFIZER INCcall$69,580,000
+346.7%
2,000,000
+300.0%
3.32%
+282.5%
MYL NewMYLAN N V$68,039,0001,146,400
+100.0%
3.25%
JAZZ NewJAZZ PHARMACEUTICALS PLC$56,157,000325,000
+100.0%
2.68%
TSRO SellTESARO INC$53,095,000
+36.0%
925,000
-11.9%
2.53%
+16.4%
MDVN SellMEDIVATION INC$48,401,000
-15.5%
375,000
-34.8%
2.31%
-27.7%
MYL NewMYLAN N Vcall$47,480,000800,000
+100.0%
2.26%
KND NewKINDRED HEALTHCARE INC$46,647,0001,960,800
+100.0%
2.23%
RAD NewRITE AID CORP$45,735,0005,262,900
+100.0%
2.18%
DHR BuyDANAHER CORP DELcall$44,148,000
+28.8%
520,000
+30.0%
2.11%
+10.2%
TEVA NewTEVA PHARMACEUTICAL INDS LTDcall$43,610,000700,000
+100.0%
2.08%
BSX SellBOSTON SCIENTIFIC CORP$42,364,000
-7.6%
2,386,700
-31.0%
2.02%
-20.9%
MRK NewMERCK & CO INC NEW$41,328,000719,000
+100.0%
1.97%
ALR NewALERE INC$39,115,000799,900
+100.0%
1.87%
WBMD SellWEBMD HEALTH CORP$37,503,000
-22.6%
855,555
-30.2%
1.79%
-33.8%
ILMN SellILLUMINA INC$36,033,000
-44.2%
194,100
-44.5%
1.72%
-52.3%
EW NewEDWARDS LIFESCIENCES CORP$35,615,000250,000
+100.0%
1.70%
BCR NewBARD C R INC$33,470,000200,000
+100.0%
1.60%
VRTX NewVERTEX PHARMACEUTICALS INC$32,442,000275,000
+100.0%
1.55%
PFE SellPFIZER INC$32,118,000
-68.0%
923,200
-71.3%
1.53%
-72.6%
RLYP NewRELYPSA INC$31,561,000875,000
+100.0%
1.51%
HYH SellHALYARD HEALTH INC$30,543,000
-29.4%
620,800
-34.7%
1.46%
-39.5%
MRK NewMERCK & CO INC NEWcall$28,740,000500,000
+100.0%
1.37%
TSRO NewTESARO INCput$28,700,000500,000
+100.0%
1.37%
PDCO NewPATTERSON COMPANIES INC$27,810,000570,000
+100.0%
1.33%
UHS SellUNIVERSAL HLTH SVCS INCcl b$26,485,000
-47.1%
225,000
-50.0%
1.26%
-54.7%
ACAD NewACADIA PHARMACEUTICALS INC$23,628,000725,000
+100.0%
1.13%
AMRI SellALBANY MOLECULAR RESH INC$22,440,000
-13.9%
1,275,000
-20.3%
1.07%
-26.2%
A BuyAGILENT TECHNOLOGIES INC$21,814,000
+122.5%
525,000
+119.2%
1.04%
+90.3%
KYTH BuyKYTHERA BIOPHARMACEUTICALS I$21,314,000
+570.9%
425,000
+364.0%
1.02%
+474.6%
TTPH NewTETRAPHASE PHARMACEUTICALS I$17,118,000467,200
+100.0%
0.82%
ABC NewAMERISOURCEBERGEN CORPput$17,051,000150,000
+100.0%
0.81%
VSAR BuyVERSARTIS INC$16,856,000
-14.2%
917,600
+4.9%
0.80%
-26.6%
TKMR NewTEKMIRA PHARMACEUTICALS CORP$12,550,000718,800
+100.0%
0.60%
AERI NewAERIE PHARMACEUTICALS INC$10,969,000350,000
+100.0%
0.52%
THC NewTENET HEALTHCARE CORPcall$10,892,000220,000
+100.0%
0.52%
THC NewTENET HEALTHCARE CORPput$10,892,000220,000
+100.0%
0.52%
IART NewINTEGRA LIFESCIENCES HLDGS C$10,789,000175,000
+100.0%
0.52%
ELGX NewENDOLOGIX INC$9,829,000575,800
+100.0%
0.47%
TMO SellTHERMO FISHER SCIENTIFIC INC$9,149,000
-81.7%
68,100
-83.0%
0.44%
-84.4%
DYAX NewDYAX CORP$8,208,000489,900
+100.0%
0.39%
DSCI SellDERMA SCIENCES INC$7,569,000
-11.6%
893,600
-2.9%
0.36%
-24.3%
GILD SellGILEAD SCIENCES INC$6,791,000
-94.2%
69,200
-94.5%
0.32%
-95.1%
ARAY NewACCURAY INC$6,761,000727,000
+100.0%
0.32%
AKBA SellAKEBIA THERAPEUTICS INC$6,605,000
-32.9%
594,534
-29.7%
0.32%
-42.5%
Q NewQUINTILES TRANSNATIO HLDGS I$6,462,00096,496
+100.0%
0.31%
ASMB NewASSEMBLY BIOSCIENCES INC$6,289,000475,000
+100.0%
0.30%
SRPT NewSAREPTA THERAPEUTICS INC$6,145,000462,700
+100.0%
0.29%
DGX NewQUEST DIAGNOSTICS INCput$5,764,00075,000
+100.0%
0.28%
DHR BuyDANAHER CORP DEL$5,527,000
+22.8%
65,100
+24.0%
0.26%
+5.2%
UNH NewUNITEDHEALTH GROUP INC$4,885,00041,300
+100.0%
0.23%
CVS NewCVS HEALTH CORP$4,438,00043,000
+100.0%
0.21%
IDRA BuyIDERA PHARMACEUTICALS INC$4,325,000
+21.3%
1,165,786
+44.2%
0.21%
+3.5%
CI NewCIGNA CORPORATION$4,292,00033,159
+100.0%
0.20%
ELOS  SYNERON MEDICAL LTD$3,261,000
+32.7%
263,4000.0%0.16%
+13.9%
OPHT NewOPHTHOTECH CORP$1,596,00034,300
+100.0%
0.08%
LENS NewPRESBIA PLC$420,00056,869
+100.0%
0.02%
CEMP ExitCEMPRA INC$0-11,408
-100.0%
-0.02%
BLCM ExitBELLICUM PHARMACEUTICALS INC$0-40,586
-100.0%
-0.05%
ACHN ExitACHILLION PHARMACEUTICALS INcall$0-100,000
-100.0%
-0.07%
XOMA ExitXOMA CORP DEL$0-450,000
-100.0%
-0.09%
KERX ExitKERYX BIOPHARMACEUTICALS INC$0-178,300
-100.0%
-0.14%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-163,600
-100.0%
-0.17%
INFI ExitINFINITY PHARMACEUTICALS INC$0-223,712
-100.0%
-0.21%
NVAX ExitNOVAVAX INC$0-649,781
-100.0%
-0.22%
VAR ExitVARIAN MED SYS INCput$0-100,000
-100.0%
-0.48%
PCRX ExitPACIRA PHARMACEUTICALS INC$0-125,000
-100.0%
-0.62%
CELG ExitCELGENE CORP$0-181,600
-100.0%
-1.13%
ZTS ExitZOETIS INCcl a$0-512,500
-100.0%
-1.23%
ALXN ExitALEXION PHARMACEUTICALS INC$0-127,100
-100.0%
-1.31%
ZBH ExitZIMMER HLDGS INC$0-264,400
-100.0%
-1.67%
CAH ExitCARDINAL HEALTH INC$0-385,200
-100.0%
-1.73%
XLV ExitSELECT SECTOR SPDR TRput$0-500,000
-100.0%
-1.91%
NUVA ExitNUVASIVE INC$0-750,000
-100.0%
-1.97%
MCK ExitMCKESSON CORP$0-175,600
-100.0%
-2.03%
MYL ExitMYLAN INC$0-698,800
-100.0%
-2.20%
ISRG ExitINTUITIVE SURGICAL INC$0-76,600
-100.0%
-2.26%
ZBH ExitZIMMER HLDGS INCcall$0-400,000
-100.0%
-2.53%
OCR ExitOMNICARE INC$0-675,000
-100.0%
-2.74%
SLXP ExitSALIX PHARMACEUTICALS INC$0-525,000
-100.0%
-3.36%
KEYS ExitKEYSIGHT TECHNOLOGIES INC$0-2,043,826
-100.0%
-3.85%
VRX ExitVALEANT PHARMACEUTICALS INTL$0-650,000
-100.0%
-5.18%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HCA HOLDINGS INC27Q1 20226.2%
ZIMMER HLDGS INC26Q2 20229.3%
DANAHER CORPORATION26Q3 20225.6%
NEUROCRINE BIOSCIENCES INC26Q4 20227.8%
UNITEDHEALTH GROUP INC24Q3 20226.4%
VERTEX PHARMACEUTICALS INC24Q3 20215.3%
HUMANA INC22Q3 20226.6%
BRISTOL-MYERS SQUIBB CO22Q3 20229.2%
BIOGEN INC21Q3 20228.5%
LABORATORY CORP AMER HLDGS20Q2 20208.3%

View HealthCor Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
HealthCor Management, L.P. Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CareView Communications IncMay 26, 2023186,970,00032.0%
Research Alliance Corp. IISold outFebruary 14, 202300.0%
ARYA Sciences Acquisition Corp IVSold outFebruary 14, 202200.0%
Aurinia Pharmaceuticals Inc.Sold outFebruary 14, 202200.0%
MADRIGAL PHARMACEUTICALS, INC.Sold outFebruary 14, 202200.0%
Medicus Sciences Acquisition Corp.Sold outFebruary 14, 202200.0%
Arcturus Therapeutics Holdings Inc.Sold outFebruary 12, 202100.0%
Intersect ENT, Inc.Sold outFebruary 12, 202100.0%
NEVRO CORPFebruary 12, 2021156,0460.5%
ViewRay, Inc.Sold outFebruary 12, 202100.0%

View HealthCor Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
42023-05-26
42023-05-26
SC 13D/A2023-05-26
42023-04-04
42023-04-04
SC 13D/A2023-04-03
13F-HR2023-02-15
SC 13G/A2023-02-14
42023-01-04
42023-01-04

View HealthCor Management, L.P.'s complete filings history.

Compare quarters

Export HealthCor Management, L.P.'s holdings